share_log

Sensata Technologies Analyst Ratings

Benzinga ·  Oct 5, 2023 09:04
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/05/2023 13.67% Truist Securities $48 → $43 Maintains Hold
09/28/2023 16.31% Stifel $48 → $44 Maintains Hold
07/26/2023 26.88% Truist Securities $52 → $48 Maintains Hold
07/26/2023 37.46% Goldman Sachs $60 → $52 Maintains Buy
04/26/2023 37.46% Truist Securities $49 → $52 Maintains Hold
02/15/2023 45.39% Stifel → $55 Downgrades Buy → Hold
02/09/2023 Wolfe Research Downgrades Outperform → Peer Perform
02/02/2023 66.53% Cowen & Co. $55 → $63 Maintains Outperform
02/01/2023 45.39% Citigroup $42 → $55 Maintains Neutral
02/01/2023 42.74% Baird $52 → $54 Maintains Neutral
11/22/2022 42.74% Jefferies $43 → $54 Upgrades Hold → Buy
10/26/2022 11.02% Citigroup $45 → $42 Maintains Neutral
10/26/2022 29.53% RBC Capital $51 → $49 Maintains Outperform
10/10/2022 26.88% Stifel $52 → $48 Maintains Buy
10/10/2022 24.24% JP Morgan $42 → $47 Maintains Neutral
07/27/2022 13.67% Truist Securities $46 → $43 Maintains Hold
07/27/2022 18.95% Citigroup $50 → $45 Maintains Neutral
07/14/2022 11.02% JP Morgan $58 → $42 Maintains Neutral
06/28/2022 32.17% Evercore ISI Group $56 → $50 Maintains In-Line
06/22/2022 45.39% Wolfe Research → $55 Upgrades Peer Perform → Outperform
06/10/2022 50.67% Morgan Stanley $62 → $57 Maintains Overweight
06/01/2022 69.18% Goldman Sachs $72 → $64 Maintains Buy
04/27/2022 63.89% Morgan Stanley $64 → $62 Maintains Overweight
04/27/2022 61.25% RBC Capital $65 → $61 Maintains Outperform
04/08/2022 45.39% Truist Securities $62 → $55 Maintains Hold
04/07/2022 66.53% Barclays $70 → $63 Maintains Overweight
02/14/2022 79.75% UBS $62 → $68 Upgrades Neutral → Buy
02/02/2022 87.68% Morgan Stanley $75 → $71 Maintains Overweight
01/14/2022 77.11% Baird → $67 Downgrades Outperform → Neutral
12/15/2021 98.26% Morgan Stanley $73 → $75 Maintains Overweight
10/18/2021 JP Morgan Downgrades Overweight → Neutral
09/21/2021 66.53% UBS → $63 Initiates Coverage On → Neutral
04/28/2021 92.97% Morgan Stanley $72 → $73 Maintains Overweight
04/28/2021 85.04% RBC Capital $66 → $70 Maintains Outperform
04/19/2021 77.11% Evercore ISI Group $60 → $67 Upgrades In-Line → Outperform
03/22/2021 90.33% Morgan Stanley $68 → $72 Maintains Overweight
03/03/2021 90.33% JP Morgan $61 → $72 Upgrades Neutral → Overweight
01/22/2021 71.82% Barclays $55 → $65 Maintains Overweight
01/11/2021 79.75% Morgan Stanley $63 → $68 Maintains Overweight
12/14/2020 66.53% Morgan Stanley $47 → $63 Upgrades Equal-Weight → Overweight
12/07/2020 Jefferies Downgrades Buy → Hold
10/28/2020 24.24% Morgan Stanley $43 → $47 Maintains Equal-Weight
10/20/2020 50.67% Baird → $57 Initiates Coverage On → Outperform
10/06/2020 45.39% Berenberg → $55 Initiates Coverage On → Buy
10/05/2020 13.67% Morgan Stanley $40 → $43 Maintains Equal-Weight
10/05/2020 45.39% Cowen & Co. $40 → $55 Upgrades Market Perform → Outperform
07/24/2020 29.53% Barclays $44 → $49 Maintains Overweight
06/16/2020 5.74% Morgan Stanley $35 → $40 Maintains Equal-Weight
05/27/2020 -7.48% Morgan Stanley → $35 Upgrades Underweight → Equal-Weight
04/30/2020 32.17% Canaccord Genuity $45 → $50 Maintains Buy
04/30/2020 0.45% SunTrust Robinson Humphrey $33 → $38 Maintains Hold
04/30/2020 11.02% Wells Fargo $40 → $42 Maintains Equal-Weight
04/30/2020 5.74% BMO Capital $44 → $40 Maintains Market Perform
04/30/2020 3.09% Citigroup $38 → $39 Maintains Neutral
04/13/2020 0.45% Goldman Sachs $55 → $38 Upgrades Neutral → Buy
04/03/2020 -12.77% SunTrust Robinson Humphrey $38 → $33 Maintains Hold
04/03/2020 18.95% Canaccord Genuity $57 → $45 Maintains Buy
04/02/2020 11.02% B of A Securities $55 → $42 Reiterates → Buy
03/18/2020 -7.48% Morgan Stanley $44 → $35 Maintains Underweight
12/17/2019 63.89% RBC Capital → $62 Initiates Coverage On → Outperform
11/22/2019 45.39% Wolfe Research → $55 Downgrades Outperform → Peer Perform
10/16/2019 Oppenheimer Downgrades Outperform → Perform
07/31/2019 16.31% Morgan Stanley $45 → $44 Maintains Underweight
06/17/2019 Longbow Research Downgrades Buy → Neutral
06/06/2019 32.17% Evercore ISI Group → $50 Initiates Coverage On → In-Line
04/22/2019 50.67% JP Morgan $60 → $57 Downgrades Overweight → Neutral
12/04/2018 55.96% Jefferies → $59 Initiates Coverage On → Buy
10/31/2018 16.31% Morgan Stanley $47 → $44 Maintains Underweight
10/31/2018 55.96% Barclays $58 → $59 Maintains Overweight
10/31/2018 37.46% Citigroup $56 → $52 Maintains Neutral
10/31/2018 61.25% Canaccord Genuity $70 → $61 Maintains Buy

What is the target price for Sensata Technologies (ST)?

The latest price target for Sensata Technologies (NYSE: ST) was reported by Truist Securities on October 5, 2023. The analyst firm set a price target for $43.00 expecting ST to rise to within 12 months (a possible 13.67% upside). 15 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Sensata Technologies (ST)?

The latest analyst rating for Sensata Technologies (NYSE: ST) was provided by Truist Securities, and Sensata Technologies maintained their hold rating.

When is the next analyst rating going to be posted or updated for Sensata Technologies (ST)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sensata Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sensata Technologies was filed on October 5, 2023 so you should expect the next rating to be made available sometime around October 5, 2024.

Is the Analyst Rating Sensata Technologies (ST) correct?

While ratings are subjective and will change, the latest Sensata Technologies (ST) rating was a maintained with a price target of $48.00 to $43.00. The current price Sensata Technologies (ST) is trading at is $37.83, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment